Usefulness of B-Type Natriuretic Peptide and C-Reactive Protein in Predicting the Presence or Absence of Left Ventricular Hypertrophy in Patients With Systemic Hypertension

Casale, 1985, Electrocardiographic detection of left ventricular hypertrophy, J Am Coll Cardiol, 6, 572, 10.1016/S0735-1097(85)80115-7 Levy, 1990, Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy, Circulation, 81, 815, 10.1161/01.CIR.81.3.815 Vasan, 2002, Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction, JAMA, 288, 1252, 10.1001/jama.288.10.1252 Ross, 1999, Atherosclerosis—an inflammatory disease, N Engl J Med, 340, 115, 10.1056/NEJM199901143400207 Sesso, 2003, C-reactive protein and the risk of developing hypertension, JAMA, 290, 2945, 10.1001/jama.290.22.2945 Palmieri, 2003, Relation of left ventricular hypertrophy to inflammation and albuminuria in adults with type 2 diabetes, Diabetes Care, 26, 2764, 10.2337/diacare.26.10.2764 Palmieri, 1999, Reliability of echocardiographic assessment of left ventricular structure and function, J Am Coll Cardiol, 34, 1625, 10.1016/S0735-1097(99)00396-4 Schiller, 1989, Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms, J Am Soc Echocardiogr, 2, 358, 10.1016/S0894-7317(89)80014-8 Devereux, 1986, Echocardiographic assessment of left ventricular hypertrophy, Am J Cardiol, 57, 450, 10.1016/0002-9149(86)90771-X 2003, 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension, J Hypertens, 21, 1011, 10.1097/00004872-200306000-00001 Wang, 2004, Plasma natriuretic peptide levels and the risk of cardiovascular events and death, N Engl J Med, 350, 655, 10.1056/NEJMoa031994 Ridker, 1997, Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men, N Engl J Med, 336, 973, 10.1056/NEJM199704033361401 Vasan, 2003, Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction, Circulation, 107, 1486, 10.1161/01.CIR.0000057810.48709.F6 Campbell, 2005, Prediction of heart failure by amino terminal-pro-B-type natriuretic peptide and C-reactive protein in subjects with cerebrovascular disease, Hypertension, 45, 69, 10.1161/01.HYP.0000151103.02424.c3